Background Gastrointestinal autonomic dysfunction (GAD) is a common complication of Type 2 Diabetes Mellitus (T2DM) leading to gastroparesis, constipation, and gastroesophageal reflux disease, consequently affecting the overall quality of life. However, its prevalence and risk factors remain underexplored, particularly in low-resource settings like Zanzibar. This study assessed the prevalence of GAD and its associations with pharmacological, clinical, and lifestyle factors among T2DM patients in Zanzibar using the Composite Autonomic Symptom Score (COMPASS 31) questionnaire. Methods A cross-sectional study was conducted among 364 T2DM patients attending clinics in Zanzibar. Participants were recruited from local healthcare facilities, and data were collected through structured interviews. The gastrointestinal subdomain of the COMPASS 31 questionnaire quantified symptoms of gastrointestinal dysfunction. Descriptive and inferential analyses were performed to explore prevalence and associated factors. Results Among 364 participants, 140 (38.4%) had GAD.
Background Gastrointestinal autonomic dysfunction (GAD) is a common complication of Type 2 Diabetes Mellitus (T2DM) leading to gastroparesis, constipation, and gastroesophageal reflux disease, consequently affecting the overall quality of life. However, its prevalence and risk factors remain underexplored, particularly in low-resource settings like Zanzibar. This study assessed the prevalence of GAD and its associations with pharmacological, clinical, and lifestyle factors among T2DM patients in Zanzibar using the Composite Autonomic Symptom Score (COMPASS 31) questionnaire. Methods A cross-sectional study was conducted among 364 T2DM patients attending clinics in Zanzibar. Participants were recruited from local healthcare facilities, and data were collected through structured interviews. The gastrointestinal subdomain of the COMPASS 31 questionnaire quantified symptoms of gastrointestinal dysfunction. Descriptive and inferential analyses were performed to explore prevalence and associated factors. Results Among 364 participants, 140 (38.4%) had GAD.
Background Gastrointestinal autonomic dysfunction (GAD) is a common complication of Type 2 Diabetes Mellitus (T2DM) leading to gastroparesis, constipation, and gastroesophageal reflux disease, consequently affecting the overall quality of life. However, its prevalence and risk factors remain underexplored, particularly in low-resource settings like Zanzibar. This study assessed the prevalence of GAD and its associations with pharmacological, clinical, and lifestyle factors among T2DM patients in Zanzibar using the Composite Autonomic Symptom Score (COMPASS 31) questionnaire. Methods A cross-sectional study was conducted among 364 T2DM patients attending clinics in Zanzibar. Participants were recruited from local healthcare facilities, and data were collected through structured interviews. The gastrointestinal subdomain of the COMPASS 31 questionnaire quantified symptoms of gastrointestinal dysfunction. Descriptive and inferential analyses were performed to explore prevalence and associated factors. Results Among 364 participants, 140 (38.4%) had GAD.
Background Gastrointestinal autonomic dysfunction (GAD) is a common complication of Type 2 Diabetes Mellitus (T2DM) leading to gastroparesis, constipation, and gastroesophageal reflux disease, consequently affecting the overall quality of life. However, its prevalence and risk factors remain underexplored, particularly in low-resource settings like Zanzibar. This study assessed the prevalence of GAD and its associations with pharmacological, clinical, and lifestyle factors among T2DM patients in Zanzibar using the Composite Autonomic Symptom Score (COMPASS 31) questionnaire. Methods A cross-sectional study was conducted among 364 T2DM patients attending clinics in Zanzibar. Participants were recruited from local healthcare facilities, and data were collected through structured interviews. The gastrointestinal subdomain of the COMPASS 31 questionnaire quantified symptoms of gastrointestinal dysfunction. Descriptive and inferential analyses were performed to explore prevalence and associated factors. Results Among 364 participants, 140 (38.4%) had GAD.
Background Gastrointestinal autonomic dysfunction (GAD) is a common complication of Type 2 Diabetes Mellitus (T2DM) leading to gastroparesis, constipation, and gastroesophageal reflux disease, consequently affecting the overall quality of life. However, its prevalence and risk factors remain underexplored, particularly in low-resource settings like Zanzibar. This study assessed the prevalence of GAD and its associations with pharmacological, clinical, and lifestyle factors among T2DM patients in Zanzibar using the Composite Autonomic Symptom Score (COMPASS 31) questionnaire. Methods A cross-sectional study was conducted among 364 T2DM patients attending clinics in Zanzibar. Participants were recruited from local healthcare facilities, and data were collected through structured interviews. The gastrointestinal subdomain of the COMPASS 31 questionnaire quantified symptoms of gastrointestinal dysfunction. Descriptive and inferential analyses were performed to explore prevalence and associated factors. Results Among 364 participants, 140 (38.4%) had GAD.
Background Gastrointestinal autonomic dysfunction (GAD) is a common complication of Type 2 Diabetes Mellitus (T2DM) leading to gastroparesis, constipation, and gastroesophageal reflux disease, consequently affecting the overall quality of life. However, its prevalence and risk factors remain underexplored, particularly in low-resource settings like Zanzibar. This study assessed the prevalence of GAD and its associations with pharmacological, clinical, and lifestyle factors among T2DM patients in Zanzibar using the Composite Autonomic Symptom Score (COMPASS 31) questionnaire. Methods A cross-sectional study was conducted among 364 T2DM patients attending clinics in Zanzibar. Participants were recruited from local healthcare facilities, and data were collected through structured interviews. The gastrointestinal subdomain of the COMPASS 31 questionnaire quantified symptoms of gastrointestinal dysfunction. Descriptive and inferential analyses were performed to explore prevalence and associated factors. Results Among 364 participants, 140 (38.4%) had GAD.
Background Gastrointestinal autonomic dysfunction (GAD) is a common complication of Type 2 Diabetes Mellitus (T2DM) leading to gastroparesis, constipation, and gastroesophageal reflux disease, consequently affecting the overall quality of life. However, its prevalence and risk factors remain underexplored, particularly in low-resource settings like Zanzibar. This study assessed the prevalence of GAD and its associations with pharmacological, clinical, and lifestyle factors among T2DM patients in Zanzibar using the Composite Autonomic Symptom Score (COMPASS 31) questionnaire. Methods A cross-sectional study was conducted among 364 T2DM patients attending clinics in Zanzibar. Participants were recruited from local healthcare facilities, and data were collected through structured interviews. The gastrointestinal subdomain of the COMPASS 31 questionnaire quantified symptoms of gastrointestinal dysfunction. Descriptive and inferential analyses were performed to explore prevalence and associated factors. Results Among 364 participants, 140 (38.4%) had GAD.
Living well with diabetes is about making informed choices that keep your blood sugar stable and support your overall health. This practical guide focuses on daily nutrition strategies that can help you feel your best while effectively managing your condition.
Building Your Blood Sugar-Friendly Plate
Creating balanced meals is the foundation of diabetes management. Follow this simple formula:
Remember: Consistency is key in diabetes management. Small, sustainable changes to your eating habits can make a significant difference in your blood sugar control and overall well-being. Work with your healthcare team to develop a personalized plan that fits your lifestyle and preferences. Track your progress, celebrate your successes, and adjust your approach as needed. Living well with diabetes is absolutely achievable with the right knowledge and daily habits.
Living well with diabetes is about making informed choices that keep your blood sugar stable and support your overall health. This practical guide focuses on daily nutrition strategies that can help you feel your best while effectively managing your condition.
Building Your Blood Sugar-Friendly Plate
Creating balanced meals is the foundation of diabetes management. Follow this simple formula:
Remember: Consistency is key in diabetes management. Small, sustainable changes to your eating habits can make a significant difference in your blood sugar control and overall well-being. Work with your healthcare team to develop a personalized plan that fits your lifestyle and preferences. Track your progress, celebrate your successes, and adjust your approach as needed. Living well with diabetes is absolutely achievable with the right knowledge and daily habits.
Living well with diabetes is about making informed choices that keep your blood sugar stable and support your overall health. This practical guide focuses on daily nutrition strategies that can help you feel your best while effectively managing your condition.
Building Your Blood Sugar-Friendly Plate
Creating balanced meals is the foundation of diabetes management. Follow this simple formula:
Remember: Consistency is key in diabetes management. Small, sustainable changes to your eating habits can make a significant difference in your blood sugar control and overall well-being. Work with your healthcare team to develop a personalized plan that fits your lifestyle and preferences. Track your progress, celebrate your successes, and adjust your approach as needed. Living well with diabetes is absolutely achievable with the right knowledge and daily habits.
